Friday, November 26, 2021

Merck’s COVID pill shows lower efficacy in updated study

Drugmaker says final analysis of trial results showed molnupiravir showed 30 percent risk reduction.
Merck’s COVID pill shows lower efficacy in updated study
read more

No comments:

Post a Comment